These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 3031397

  • 1. Site of inhibitory action of CRE 9-41 on ACTH release from isolated rat pituitary cells.
    Rosenthal MJ, Kraner JC, Peake GT.
    Life Sci; 1987 Mar 23; 40(12):1179-84. PubMed ID: 3031397
    [Abstract] [Full Text] [Related]

  • 2. Regulation of corticotropin-releasing factor (CRF) receptors in the rat pituitary gland: effects of adrenalectomy on CRF receptors and corticotroph responses.
    Wynn PC, Harwood JP, Catt KJ, Aguilera G.
    Endocrinology; 1985 Apr 23; 116(4):1653-9. PubMed ID: 2982594
    [Abstract] [Full Text] [Related]

  • 3. Somatostatin inhibits corticotropin-releasing factor-stimulated adrenocorticotropin release, adenylate cyclase, and activation of adenosine 3',5'-monophosphate-dependent protein kinase isoenzymes in AtT20 cells.
    Litvin Y, Leiser M, Fleischer N, Erlichman J.
    Endocrinology; 1986 Aug 23; 119(2):737-45. PubMed ID: 2426087
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interactions between CRF, epinephrine, vasopressin and glucocorticoids in the control of ACTH secretion.
    Labrie F, Giguere V, Proulx L, Lefevre G.
    J Steroid Biochem; 1984 Jan 23; 20(1):153-60. PubMed ID: 6323861
    [Abstract] [Full Text] [Related]

  • 6. A comparative study of the role of adenylate cyclase in the release of adrenocorticotropin from the ovine and rat anterior pituitary.
    Liu JP, Robinson PJ, Funder JW, Engler D.
    Mol Cell Endocrinol; 1994 May 23; 101(1-2):173-81. PubMed ID: 9397950
    [Abstract] [Full Text] [Related]

  • 7. Role of cyclic AMP in corticotropin releasing factor mediated ACTH release.
    Sobel DO.
    Peptides; 1985 May 23; 6(4):591-5. PubMed ID: 2415953
    [Abstract] [Full Text] [Related]

  • 8. Desensitization of corticotropin-releasing factor receptors.
    Reisine T, Hoffman A.
    Biochem Biophys Res Commun; 1983 Mar 29; 111(3):919-25. PubMed ID: 6301492
    [Abstract] [Full Text] [Related]

  • 9. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
    Spinedi E, Giacomini M, Jacquier MC, Gaillard RC.
    Neuroendocrinology; 1991 Feb 29; 53(2):160-70. PubMed ID: 1849620
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Importance of pituitary and brain receptors for corticotrophin-releasing factor in modulating alcohol-induced ACTH secretion in the rat.
    Rivier C, Rivier J, Lee S.
    Brain Res; 1996 May 20; 721(1-2):83-90. PubMed ID: 8793087
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of protein phosphatases by okadaic acid and calyculin-A differentially modulates hormonal- and forskolin-stimulated formation of cyclic AMP in AtT-20 corticotrophs: effect of pituitary adenylate activating polypeptide and corticotropin-releasing factor.
    Koch B, Lutz-Bucher B.
    Cell Signal; 1994 May 20; 6(4):467-73. PubMed ID: 7946970
    [Abstract] [Full Text] [Related]

  • 14. Rapid as well as delayed inhibitory effects of glucocorticoid hormones on pituitary adrenocorticotropic hormone release are mediated by type II glucocorticoid receptors and require newly synthesized messenger ribonucleic acid as well as protein.
    Dayanithi G, Antoni FA.
    Endocrinology; 1989 Jul 20; 125(1):308-13. PubMed ID: 2544406
    [Abstract] [Full Text] [Related]

  • 15. Hormonal activation of the cAMP-dependent protein kinases in AtT20 cells. Preferential activation of protein kinase I by corticotropin releasing factor, isoproterenol, and forskolin.
    Litvin Y, PasMantier R, Fleischer N, Erlichman J.
    J Biol Chem; 1984 Aug 25; 259(16):10296-302. PubMed ID: 6088493
    [Abstract] [Full Text] [Related]

  • 16. In vivo and in vitro release of ACTH by synthetic CRF.
    Turkelson CM, Arimura A, Culler MD, Fishback JB, Groot K, Kanda M, Luciano M, Thomas CR, Chang D, Chang JK, Shimizu M.
    Peptides; 1981 Aug 25; 2(4):425-9. PubMed ID: 6276870
    [Abstract] [Full Text] [Related]

  • 17. Arginine vasopressin is a much more potent stimulus to ACTH release from ovine anterior pituitary cells than ovine corticotropin-releasing factor. 1. In vitro studies.
    Familari M, Smith AI, Smith R, Funder JW.
    Neuroendocrinology; 1989 Aug 25; 50(2):152-7. PubMed ID: 2550836
    [Abstract] [Full Text] [Related]

  • 18. Site of calcium requirement for stimulation of ACTH release in rat anterior pituitary cells in culture by synthetic ovine corticotropin-releasing factor.
    Giguere V, Lefevre G, Labrie F.
    Life Sci; 1982 Dec 27; 31(26):3057-62. PubMed ID: 6298539
    [Abstract] [Full Text] [Related]

  • 19. Receptor-mediated actions of corticotropin-releasing factor in pituitary gland and nervous system.
    Aguilera G, Wynn PC, Harwood JP, Hauger RL, Millan MA, Grewe C, Catt KJ.
    Neuroendocrinology; 1986 Dec 27; 43(1):79-88. PubMed ID: 3012395
    [Abstract] [Full Text] [Related]

  • 20. The effect of nifedipine on CRF-41 and AVP-induced ACTH release in vitro.
    Murakami K, Hashimoto K, Ota Z.
    Acta Endocrinol (Copenh); 1985 May 27; 109(1):32-6. PubMed ID: 2988257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.